AzTrials
AzTrials

Small-cell Lung CancerSUCCEEDNCT06486428

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

An observational study of Small-cell Lung Cancer, run by Addario Lung Cancer Medical Institute at 52 sites in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Small-cell Lung Cancer
How many people
22 participants
Where
52 sitesUnited States
Study dates
23 May 2025to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults (USA-based) with a diagnosis of extensive stage primary SCLC or tSCLC

Who may be able to join

  • Men or women greater than or equal to 18 years of age at the time of consent
  • Ability to read, write and communicate in English
  • Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)
  • Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required
  • Willing to comply with the requirements of the study
  • Diagnosis of extensive stage primary SCLC or tSCLC

Who cannot join

  • Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements
  • Subjects who previously enrolled to this study
  • Note: Concurrent enrollment in other clinical trials is NOT exclusionary

Trial locations and contacts

52 sites in 1 country.

52 sites in 1 country

United States52 sites

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Alabama, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Alaska, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Arizona, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Arkansas, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, California, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Colorado, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Connecticut, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Delaware, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, District of Columbia, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Florida, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Georgia, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Hawaii, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Idaho, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Illinois, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Indiana, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Iowa, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Kansas, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Kentucky, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Louisiana, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Maine, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Maryland, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Massachusetts, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Michigan, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Minnesota, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Mississippi, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Missouri, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Montana, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Nebraska, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Nevada, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, New Hampshire, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, New Jersey, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, New Mexico, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, New York, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, North Carolina, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, North Dakota, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Ohio, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Oklahoma, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Oregon, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Pennsylvania, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Rhode Island, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, South Carolina, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, South Dakota, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Tennessee, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Texas, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Utah, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Vermont, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Virginia, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Washington, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, West Virginia, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Wisconsin, 37232

  • Https://Alcmi.Org/Clinical-Trials/Current-Studies/Succeed-Study.Html

    Multiple Locations, Wyoming, 37232

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, 37232

Other trials in United States

About this study

Official title: A Study to Evaluate a Remote, Decentralized, Direct-to-Patient Strategy for Clinical Research Engagement of Patients With Small Cell Lung Cancer (SCLC).

This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.

Read the detailed description

This is a non-interventional, non-treatment, non-randomized, single coordinating center, study to determine the feasibility of decentralized bio-specimen collection in USA-based adult subjects with SCLC, to be conducted in conformance with Good Clinical Practices. Potential study subjects will be referred to contact staff through a dedicated study webpage form or dedicated study phone hotline at the coordinating center (ALCMI) who will handle informed consent, coordinate remote blood sample collection with study subjects, and collect medical records to confirm diagnosis and treatment history. Subjects will also be asked to complete a baseline and follow up questionnaire/survey documenting their self-report diagnosis, treatment history, factors impacting care and quality of life, and needs/preferences regarding supportive resources.

Patients who have been diagnosed with either extensive stage primary SCLC or patients diagnosed with primary NSCLC who experienced histological "transformation" with a SCLC component after initial diagnosis and subsequent treatment (transformed SCLC; tSCLC) will be invited to volunteer for this study.

Keywords
SCLC, Lung Cancer
Medical subject headings
Small Cell Lung Carcinoma, Lung Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06486428
Study groupRoleWhat they receive
SCLC (primary de novo)Blood collection, survey (baseline and Month 3)
SCLC (transformed)Blood collection, survey (baseline and Month 3)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of conducting trial in SCLC population

    Percentage of overall eligible subjects enrolled. Percentage of primary SCLC eligible subjects enrolled. Percentage of tSCLC eligible subjects enrolled. Percentage of SCLC eligible subjects enrolled compared to percentage of tSCLC eligible subjects enrolled. Percentage of primary SCLC enrolled subjects completed. Percentage of tSCLC enrolled subjects completed. Percentage of SCLC enrolled subjects completed compared to percentage of tSCLC enrolled subjects completed. Overall reasons for early termination. Reasons for early termination from trial in primary SCLC enrolled. Reasons for early termination from trial in tSCLC enrolled.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2024
  2. Study start23 May 2025
  3. Primary completion15 Jul 2026
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06486428
Sponsor's protocol ID
ALCMI-023
Acronym
SUCCEED
Status last verified
Aug 2026
First submitted
15 Dec 2023
Last updated
4 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Small-cell Lung Cancer, run by Addario Lung Cancer Medical Institute at 52 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 4 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 52 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of conducting trial in SCLC population (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06486428.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in